ENSG vs. ABBV
ENSG (The Ensign Group, Inc.) and ABBV (AbbVie Inc.) are both stocks. Both are in the Healthcare sector — ENSG in Medical Care Facilities, ABBV in Drug Manufacturers - General. Over the past 10 years, ENSG returned 24.21%/yr vs 18.75%/yr for ABBV. At a 0.27 correlation, their price movements are largely independent.
Performance
ENSG vs. ABBV - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ENSG achieves a -13.46% return, which is significantly lower than ABBV's -1.43% return. Over the past 10 years, ENSG has outperformed ABBV with an annualized return of 24.21%, while ABBV has yielded a comparatively lower 18.75% annualized return.
ENSG
- 1D
- 0.90%
- 1M
- -15.17%
- YTD
- -13.46%
- 6M
- -14.84%
- 1Y
- -0.20%
- 3Y*
- 17.03%
- 5Y*
- 12.40%
- 10Y*
- 24.21%
ABBV
- 1D
- -2.70%
- 1M
- 5.32%
- YTD
- -1.43%
- 6M
- -0.98%
- 1Y
- 19.75%
- 3Y*
- 21.19%
- 5Y*
- 18.27%
- 10Y*
- 18.75%
ENSG vs. ABBV - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
ENSG The Ensign Group, Inc. | -13.46% | 31.33% | 18.62% | 18.89% | 12.98% | 15.43% | 61.43% | 25.53% | 75.67% | 0.78% |
ABBV AbbVie Inc. | -1.43% | 33.08% | 18.86% | -0.23% | 24.01% | 32.43% | 27.72% | 1.47% | -0.96% | 60.07% |
Correlation
The correlation between ENSG and ABBV is 0.22, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.22 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.22 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.22 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.25 |
Correlation (All Time) Calculated using the full available price history since Jan 2, 2013 | 0.27 |
Fundamentals
ENSG:
$8.98B
ABBV:
$393.10B
ENSG:
$6.15
ABBV:
$2.05
ENSG:
24.51
ABBV:
107.96
ENSG:
1.69
ABBV:
6.25
ENSG:
3.79
ABBV:
14.30
ENSG:
$5.27B
ABBV:
$62.82B
ENSG:
$800.38M
ABBV:
$46.15B
ENSG:
$590.49M
ABBV:
$17.96B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ENSG vs. ABBV — Risk / Return Rank
ENSG
ABBV
ENSG vs. ABBV - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for The Ensign Group, Inc. (ENSG) and AbbVie Inc. (ABBV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| ENSG | ABBV | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.82 | ||
| Sortino ratioReturn per unit of downside risk | -1.07 | ||
| Omega ratioGain probability vs. loss probability | 1.03 | 1.16 | -0.13 |
| Calmar ratioReturn relative to maximum drawdown | -0.01 | 1.15 | -1.15 |
| Martin ratioReturn relative to average drawdown | -0.02 | 2.55 | -2.58 |
Loading charts...
Drawdowns
ENSG vs. ABBV - Drawdown Comparison
The maximum ENSG drawdown since its inception was -55.57%, which is greater than ABBV's maximum drawdown of -45.09%. Use the drawdown chart below to compare losses from any high point for ENSG and ABBV.
Loading charts...
Drawdown Indicators
| ENSG | ABBV | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -55.57% | -45.09% | -10.48% |
Max Drawdown (1Y)Largest decline over 1 year | -31.81% | -17.32% | -14.49% |
Max Drawdown (3Y)Largest decline over 3 years | -31.81% | -20.74% | -11.07% |
Max Drawdown (5Y)Largest decline over 5 years | -31.81% | -21.92% | -9.89% |
Max Drawdown (10Y)Largest decline over 10 years | -55.57% | -45.09% | -10.48% |
Current DrawdownCurrent decline from peak | -30.15% | -7.17% | -22.98% |
Average DrawdownAverage peak-to-trough decline | -12.26% | -10.71% | -1.55% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 9.38% | 7.75% | +1.63% |
Volatility
ENSG vs. ABBV - Volatility Comparison
The Ensign Group, Inc. (ENSG) has a higher volatility of 11.03% compared to AbbVie Inc. (ABBV) at 6.82%. This indicates that ENSG's price experiences larger fluctuations and is considered to be riskier than ABBV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ENSG | ABBV | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 11.03% | 6.82% | +4.21% |
Volatility (6M)Calculated over the trailing 6-month period | 22.54% | 18.06% | +4.48% |
Volatility (1Y)Calculated over the trailing 1-year period | 28.22% | 24.50% | +3.72% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 26.73% | 22.93% | +3.80% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 36.10% | 25.75% | +10.35% |
Dividends
ENSG vs. ABBV - Dividend Comparison
ENSG's dividend yield for the trailing twelve months is around 0.17%, less than ABBV's 3.04% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ABBV AbbVie Inc. | 3.04% | 2.87% | 3.49% | 3.82% | 3.49% | 3.84% | 4.41% | 4.83% | 3.89% | 2.65% | 3.64% | 3.41% |
ENSG The Ensign Group, Inc. | 0.17% | 0.14% | 0.18% | 0.21% | 0.24% | 0.25% | 0.28% | 0.40% | 0.47% | 0.78% | 0.73% | 0.67% |
Financials
ENSG vs. ABBV - Financials Comparison
This section allows you to compare key financial metrics between The Ensign Group, Inc. and AbbVie Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
ENSG vs. ABBV - Profitability Comparison
ENSG - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, The Ensign Group, Inc. reported a gross profit of 293.37M and revenue of 1.39B. Therefore, the gross margin over that period was 21.1%.
ABBV - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, AbbVie Inc. reported a gross profit of 12.53B and revenue of 15.00B. Therefore, the gross margin over that period was 83.5%.
ENSG - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, The Ensign Group, Inc. reported an operating income of 124.85M and revenue of 1.39B, resulting in an operating margin of 9.0%.
ABBV - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, AbbVie Inc. reported an operating income of 4.73B and revenue of 15.00B, resulting in an operating margin of 31.6%.
ENSG - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, The Ensign Group, Inc. reported a net income of 99.67M and revenue of 1.39B, resulting in a net margin of 7.2%.
ABBV - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, AbbVie Inc. reported a net income of 699.00M and revenue of 15.00B, resulting in a net margin of 4.7%.
Frequently Asked Questions
ENSG and ABBV have a correlation of 0.22, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ENSG has higher volatility (11.03%) compared to ABBV (6.82%). In terms of maximum drawdown, ENSG dropped -55.57% vs ABBV's -45.09%.
ABBV currently has the higher Sharpe Ratio (0.81 vs -0.01), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ENSG and ABBV
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer